Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge.
Crocs (CROX) is attracting fresh attention as management focuses on operational execution, with debt reduction, aggressive share repurchases, and targeted marketing in markets such as China and India helping to offset softer demand in North America.
See our latest analysis for Crocs.
At a share price of $85.81, Crocs has seen an 8.83% 90 day share price return, while the 1 year total shareholder return of 8.10% and 3 year total shareholder return of 25.58% point to fading momentum compared with earlier gains. This comes as recent UBS commentary highlighted a wait and see stance ahead of upcoming earnings and margin updates.
If this has you thinking about where else growth stories might emerge, it could be a good time to check out our screener of 22 top founder-led companies as potential next ideas to research.
With Crocs trading at $85.81, showing mixed recent returns and sitting only slightly below one analyst price target, the key question is whether a reported 62% intrinsic discount hints at mispricing or whether the market already reflects the future growth story.
According to Joey8301’s narrative, Crocs’ fair value sits at $151.43 per share compared with the latest close of $85.81, which creates a wide valuation gap that hinges on how the growth and profitability story plays out.
• Revenue Growth Rate: 3% Annually. This assumption reflects a modest but steady growth outlook, considering Crocs recent revenue trends and industry conditions. The company has seen strong historical growth, but with HEYDUDES struggles and a maturing core business, a 3% CAGR is a reasonable expectation based on managements guidance and analyst projections.
Curious how a modest growth rate can still back a much higher price tag? The narrative leans heavily on durable margins and a valuation multiple that assumes Crocs keeps converting those earnings into long term value.
Result: Fair Value of $151.43 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, lingering HEYDUDE weakness and any hit from tariffs or higher production costs could compress margins and make that 62% intrinsic discount look far less compelling.
Find out about the key risks to this Crocs narrative.
If you see the story differently or want to stress test your own assumptions against the same data, you can build a custom view in minutes: Do it your way
A great starting point for your Crocs research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
If you are serious about finding your next opportunity, do not stop at a single stock view. Use the tools already built for you and widen your net.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CROX.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com